Carlsbad, CA – March 31, 2006 – Next Pharmaceuticals, Inc. announced today that they are conducting a consumer awareness campaign on Seditol, their new dietary supplement blend of proprietary ingredients that helps to turn off stress to allow consumers to achieve a good night’s sleep. Seditol is an all natural blend of a patented extract from Magnolia officinalis and a proprietary extract from Ziziphus spinosa.
According to the US Government Health and Human Services Office of Women’s Health, about 60 million Americans each year suffer from insomnia, which can lead to serious sleep deficits and problems. Insomnia tends to increase with age and affects about 40 percent of women and 30 percent of men.
“Both men and women suffer from insomnia and what many don’t know is that there is something that can be done about it,” said Deanne Dolnick, Director of Sales. “Seditol is an effective and safe dietary supplement that is helping a lot of people who prefer a natural approach to managing their sleeplessness.”
A recent study at the Sleep Research and Treatment Center, Department of Psychiatry, Pennsylvania State University College of Medicine has demonstrated that the leading cause of sleeplessness in otherwise healthy adults is an overactive central nervous system with associated elevation of stress hormones. The scientists concluded from this study that the therapeutic goal in sleeplessness is to decrease the level of physical and emotional arousal, and not just improve nighttime sleep. Seditol was developed to uniquely address the need to decrease nighttime physical and emotional arousal while providing a feeling of relaxation and less worry.
A forty-five person study utilizing Seditol was conducted by an independent research organization in March, 2005. The subjects in this study reported the following results:
• 91% said Seditol helps ensure a sound night's sleep
• 89% said Seditol allows you to wake up feeling refreshed
• 91% said Seditol reduces fatigue due to lack of sleep
• 96% said Seditol is gentle to your stomach
Next Pharmaceuticals, Inc. has two patents on the Magnolia portion of Seditol®.
About Next Pharmaceuticals, Inc.
Next Pharmaceuticals, Inc. is a research and development company that markets its patented or patent-pending ingredients such as Relora®, Nexrutine®, Seditol® and Citri-Z™ to food, beverage, and dietary supplement companies seeking differentiation and a marketing edge with their healthy living products.
# # #